EMA recommends suspending a number of medicines
15.01.15
It is unfortunate that a clinical research organisation has failed to meet the very strict standards required by the regulatory authorities, however EFPIA recognises that the announcement from the EMA is evidence that the European regulatory system can detect such issues and take prompt action. It demonstrates we have a system that works.